Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3989533 | Journal of Thoracic Oncology | 2015 | 8 Pages |
Abstract
Contralateral tumors in NSCLC carry a more favorable prognosis than other M1a or M1b disease. Primary tumor size and N stage may help distinguish M1a-contra patients with hematogenous metastasis from those with a synchronous, second primary.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Zachary S. MD, PhD, Donald M. MD, Brett A. BA, Søren M. PhD, DMSc, Kevin R. MD, PhD,